Commentary by:
Daniel O. Lee, MD
Neurologist
Baptist Health Neurology
Richmond, Kentucky
The Efficacy of Gabapentin Enacarbil (GEn) in Adult Patients with Severe Primary Restless Legs Syndrome (RLS): Pooled Analyses from ...
Daniel O. Lee, William Ondo, Alon Y. Avidan, Diego García-Borreguero, Mark Jaros, Richard Kim, Gwendoline Shang
Commentary by:
Anne M. Calkins, MD, FACEP
Medical Director, Onondaga County
Correct Care Solutions
Syracuse, New York
Peripheral Edema and Weight Gain in Adult Patients with Painful Diabetic Peripheral Neuropathy Receiving Gabapentin Enacarbil ...
Anne M. Calkins, Joseph Shurman, Mark Jaros, Richard Kim, Gwendoline Shang

Peripheral Edema and Weight Gain in Adult Patients With Painful Diabetic Peripheral Neuropathy Receiving Gabapentin Enacarbil or Pregabalin Enrolled in a Randomized, Phase 2 Trial
Platform session presented by Anne M. Calkins, MD, FACEP at the American Academy of Neurology’s 66th Annual Meeting
Commentary by:
William G. Ondo, MD
Professor of Neurology
The University of Texas Health Science Center at Houston
Houston, Texas
The Effect of Prior Exposure to Dopamine Agonists (DA) on Response to Treatment with Gabapentin Enacarbil in Adult Patients ...
William G. Ondo, Neal Hermanowicz, Diego García-Borreguero, Mark Jaros, Richard Kim, Gwendoline Shang